PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $110,000 | -42.1% | 29,048 | -22.4% | 0.00% | – |
| Q4 2019 | $190,000 | +31.9% | 37,417 | +31.3% | 0.00% | – |
| Q3 2019 | $144,000 | +5.9% | 28,502 | +22.0% | 0.00% | – |
| Q2 2019 | $136,000 | +17.2% | 23,361 | -5.8% | 0.00% | – |
| Q1 2019 | $116,000 | -86.6% | 24,812 | -88.0% | 0.00% | – |
| Q4 2018 | $868,000 | +605.7% | 206,511 | +956.9% | 0.00% | – |
| Q3 2018 | $123,000 | +1.7% | 19,540 | +29.7% | 0.00% | – |
| Q2 2018 | $121,000 | -95.0% | 15,061 | -95.4% | 0.00% | -100.0% |
| Q1 2018 | $2,436,000 | +362.2% | 326,562 | +268.7% | 0.00% | – |
| Q4 2017 | $527,000 | -27.4% | 88,570 | +15.1% | 0.00% | – |
| Q1 2017 | $726,000 | +31.8% | 76,925 | -30.0% | 0.00% | – |
| Q3 2013 | $551,000 | +5.2% | 109,849 | -6.4% | 0.00% | – |
| Q2 2013 | $524,000 | – | 117,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|